跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 193 条关于
“FLT3L”
全部
193
临床试验
142
药物
31
机构
0
资讯
20
上个月
Fc Fusion Therapeutics Market Poised to Reach $53.5 Billion by 2035 as Oncology Pipeline Expands
19天前
Engineered Probiotic Carriers Emerge as Living Drug Factories for Tumor-Targeted Therapy
11个月前
Researchers Develop Gene Signature to Predict Immunotherapy Response in Triple-Negative Breast Cancer
去年
Pipeline Progress: Over 25 New Therapies in Development for Metastatic Liver Cancer
去年
Curis' Emavusertib Shows Promise in FLT3-Mutated AML Patients
去年
Emavusertib Shows Promise in FLT3-Mutated AML Patients Resistant to Prior Therapies
去年
Gilteritinib Shows Promise as ALK Inhibitor in Acute Myeloid Leukemia
去年
NHS England Fast-Tracks Quizartinib for FLT3-ITD Positive Acute Myeloid Leukemia
去年
Daiichi Sankyo's Vanflyta Enters Phase 3 Trial for FLT3-ITD Negative AML
2年前
Hemogenyx's FLT3 Assay Ready for HEMO-CAR-T Phase I Trials in AML
第 1 页,共 2 页
上一页
下一页